Kyowa Kirin International plc.

About Kyowa Kirin International plc.

Kyowa Kirin International plc. is a global biopharmaceutical company headquartered in the UK, dedicated to the research, development, and commercialization of innovative medicines. With a strong focus on unmet medical needs, the company aims to improve the quality of life for patients worldwide.

Founded on the principles of science and compassion, Kyowa Kirin International is committed to advancing healthcare through its diverse portfolio of products. The company specializes in areas such as oncology, nephrology, and immunology, striving to deliver effective therapies that address critical health challenges.

Kyowa Kirin International prides itself on its robust research and development capabilities, leveraging cutting-edge technology and scientific expertise. The company collaborates with leading academic institutions and industry partners to foster innovation and accelerate the development of new treatments.

In addition to its commitment to scientific excellence, Kyowa Kirin International places a strong emphasis on corporate social responsibility. The company actively engages in initiatives that promote sustainability, ethical practices, and community well-being.

With a dedicated team of professionals, Kyowa Kirin International is poised to make significant contributions to the global healthcare landscape. The company’s vision is to be a trusted partner in health, delivering transformative solutions that enhance patient outcomes.

• Core Areas: Oncology, Nephrology, Immunology
• Commitment: Innovation, Quality of Life, Patient-Centric Solutions
• Values: Science, Compassion, Integrity

As Kyowa Kirin International continues to grow, it remains steadfast in its mission to bring hope and healing to patients around the world.